Does Discordancy Between the CD4 Count and CD4 Percentage in HIV-Positive Individuals Influence Outcomes on Highly Active Antiretroviral Therapy?
Open Access
- 15 February 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 205 (4) , 540-547
Abstract
Introduction. The CD4 count and CD4 percentage (CD4%) are both strong predictors of clinical disease progression in human immunodeficiency virus (HIV). Although individuals may show discordancy between their CD4 count and CD4%, the clinical relevance of this is unclear. Methods. Discordancy was defined where the CD4% was ≤10th percentile for a selected CD4 count range (referred to as low discordancy), within the central 80% range (concordant), or ≥90th percentile (high discordancy). Regression methods identified factors associated with low and high discordancy in untreated individuals and assessed the impact of discordancy on treatment responses to highly active antiretroviral therapy (HAART). Results. High discordancy was associated with female sex, low viral load, and white ethnicity; low discordancy was associated with black or nonwhite ethnicity, older age, and injection drug use. Clinical event rates were higher in individuals with high discordancy starting HAART, but there was no association with subsequent HIV progression by 6 months after starting HAART. CD4 count increases remained lower, by 20 cells/mm3, in individuals with low discordancy, and higher, by 27 cells/mm3, in those with high discordancy. Conclusions. Overall discrepancies between the CD4/CD4% are small, confirming the use of absolute CD4 counts as a monitoring tool.Keywords
This publication has 22 references indexed in Scilit:
- Race/Ethnicity and Risk of AIDS and Death Among HIV-infected Patients with Access to CareJournal of General Internal Medicine, 2009
- Limited Impact of the Thymus on Immunological Recovery During and After Chemotherapy in Patients with Diffuse Large B-cell LymphomaScandinavian Journal of Immunology, 2009
- Gender Differences in HIV Progression to AIDS and Death in Industrialized Countries: Slower Disease Progression Following HIV Seroconversion in WomenAmerican Journal of Epidemiology, 2008
- Absolute Count and Percentage of CD4+Lymphocytes Are Independent Predictors of Disease Progression in HIV‐Infected Persons Initiating Highly Active Antiretroviral TherapyThe Journal of Infectious Diseases, 2007
- Assessment of the efficacy of total lymphocyte counts as predictors of AIDS defining infections in HIV-1 infected peoplePostgraduate Medical Journal, 2005
- The creation of a large UK‐based multicentre cohort of HIV‐infected individuals: The UK Collaborative HIV Cohort (UK CHIC) StudyHIV Medicine, 2004
- Do gender differences in CD4 cell counts matter?AIDS, 1999
- CD4+ T-Lymphocyte Counts in HIV InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- Lymphocyte subset reference ranges in adult caucasiansClinical Immunology and Immunopathology, 1991
- The associations of race, cigarette smoking, and smoking cessation to measures of the immune system in middle-aged menClinical Immunology and Immunopathology, 1991